62068 Federal Register / Vol. 76, No. 194 / Thursday, October 6, 2011 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Delegation of Authorities 

Notice is hereby given that I have 

delegated to the Administrator, Centers 

for Medicare & Medicaid Services 

(CMS), and the Commissioner, Food and 

Drug Administration (FDA), with 

authority to re-delegate, the authorities 

vested in the Secretary of the 

Department of Health and Human 

Services under Section 6004 of the 

Patient Protection and Affordable Care 

Act, Public Law 111–148, which adds 

Section 1128H [42 U.S.C. 1320a–7i] to 

the Social Security Act. 

I hereby delegate to CMS the authority 

vested in the Secretary to issue guidance 

and take other appropriate actions, to 

the extent that Section 1128H [42 U.S.C. 

1320a–7i] relates to Titles XVIII 

(Medicare), XIX (Medicaid), or XXI 

(State Children’s Health Insurance 

Program) of the Social Security Act. 

I hereby delegate to FDA all other 

authority vested in the Secretary under 

Section 1128H [42 U.S.C. 1320a–7i]. 

This shall include, but is not limited to, 

issuing guidance and taking other 

appropriate action to the extent that 

Section 1128H [42 U.S.C. 1320a–7i] 

relates to Section 503 of the Federal 

Food, Drug, and Cosmetic Act; 

identifying the information to be 

collected as allowed by Sections 

1128H(a)(1)(B) [42 U.S.C. 1320a– 

7i(a)(1)(B)] and 1128H(a)(2)(B) [42 

U.S.C. 1320a–7i(a)(2)(B)]; and generally, 

with respect to the information to be 

submitted under Section 1128H(a) [42 

U.S.C. 1320a–7i(a)], issuing guidance 

and taking other appropriate action to 

identify the information to be submitted 

and the manner of submission, and 

overseeing and making arrangements for 

the collection, maintenance, and 

availability of such information. 

This delegation shall be exercised in 

accordance with the Department’s 

applicable policies, procedures, and 

guidelines. 

I hereby affirm and ratify any actions 

taken by the Administrator, CMS, the 

Commissioner, FDA, or other CMS and 

FDA officials, which involve the 

exercise of these authorities prior to the 

effective date of this delegation. 

This delegation of authorities is 

effective upon date of signature. 

Authority: 44 U.S.C. 3101. 

Dated: September 30, 2011. 

Kathleen Sebelius, 

Secretary of Health and Human Services. 

[FR Doc. 2011–25851 Filed 10–5–11; 8:45 am] 

BILLING CODE 4150–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

10(a) of the Federal Advisory Committee 

Act, 5 U.S.C. App. 2, this notice 

announces a meeting of the National 

Advisory Council for Healthcare 

Research and Quality. 

DATES: The meeting will be held on 

Friday, November 4, 2011, from 8:30 

a.m. to 3:30 p.m. 

ADDRESSES: The meeting will be held at 

the Hubert H. Humphrey Building, 

Room 800, 200 Independence Avenue, 

SW., Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

Karen Brooks, Coordinator of the 

Advisory Council, at the Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850, (301) 427–1801. For press-related 

information, please contact Karen 

Migdail at (301) 427–1855. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than 

October 21, 2011. The agenda, roster, 

and minutes are available from Ms. 

Bonnie Campbell, Committee 

Management Officer, Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850. Ms. Campbell’s phone number is 

(301) 427–1554. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

The National Advisory Council for 

Healthcare Research and Quality is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) Priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Friday, November 4, there will be 

a subcommittee meeting for the National 

Healthcare Quality and Disparities 

Report scheduled to begin at 7:30 a.m. 

The Council meeting will convene at 

8:30 a.m., with the call to order by the 

Council Chair and approval of previous 

Council summary notes. The AHRQ 

Director will present her update on 

current research, programs, and 

initiatives. The final agenda will be 

available on the AHRQ Web site at 

http://www.ahrq.gov no later than 

October 31, 2011. 

Dated: September 26, 2011. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2011–25692 Filed 10–5–11; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–11–11KS] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Daniel Holcomb, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS D–74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

mstockstill on DSK4VPTVN1PROD with NOTICES